AllianceBernstein
IGMS

AllianceBernstein’s IGM Biosciences IGMS Stock Holding History

AllianceBernstein’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39,200
Closed -$45.1K – 3273
2025
Q1 		$45.1K Hold
39,200
– – ﹤0.01% 3142
2024
Q4 		$240K Sell
39,200
-2,030
-5% -$24.1K ﹤0.01% 2978
2024
Q3 		$682K Hold
41,230
– – ﹤0.01% 2504
2024
Q2 		$283K Buy
41,230
+8,930
+28% +$76.4K ﹤0.01% 2934
2024
Q1 		$312K Hold
32,300
– – ﹤0.01% 2784
2023
Q4 		$268K Sell
32,300
-3,060
-9% -$17.8K ﹤0.01% 2890
2023
Q3 		$295K Buy
35,360
+2,590
+8% +$22K ﹤0.01% 2818
2023
Q2 		$302K Buy
32,770
+6,870
+27% +$77K ﹤0.01% 2857
2023
Q1 		$356K Hold
25,900
– – ﹤0.01% 2708
2022
Q4 		$441K Buy
25,900
+1,604
+7% +$32.1K ﹤0.01% 2694
2022
Q3 		$552K Sell
24,296
-604
-2% -$12.2K ﹤0.01% 2601
2022
Q2 		$449K Buy
24,900
+9,900
+66% +$176K ﹤0.01% 2720
2022
Q1 		$401K Hold
15,000
– – ﹤0.01% 2766
2021
Q4 		$440K Hold
15,000
– – ﹤0.01% 2797
2021
Q3 		$986K Sell
15,000
-500
-3% -$38.3K ﹤0.01% 2498
2021
Q2 		$1.29M Buy
15,500
+3,500
+29% +$259K ﹤0.01% 2422
2021
Q1 		$920K Sell
12,000
-1,000
-8% -$91K ﹤0.01% 2446
2020
Q4 		$1.15M Sell
13,000
-100
-0.8% -$7.03K ﹤0.01% 2235
2020
Q3 		$967K Buy
13,100
+2,100
+19% +$124K ﹤0.01% 2202
2020
Q2 		$803K Buy
11,000
+2,700
+33% +$164K ﹤0.01% 2312
2020
Q1 		$466K Buy
+8,300
New +$364K ﹤0.01% 2391

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AllianceBernstein's IGMS Position: Q2 2025 in Review

AllianceBernstein sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 39,200 shares — an estimated $45.1K sold.

AllianceBernstein first reported a position in IGMS in Q1 2020 and held it in 21 quarters. The position peaked at $1.29M in Q2 2021. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • AllianceBernstein reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 39,200 IGM Biosciences shares in Q2 2025, an estimated $45.1K.
  • AllianceBernstein first reported a position in IGM Biosciences in Q1 2020 and held it in 21 quarters.
  • AllianceBernstein's IGM Biosciences position peaked at $1.29M in Q2 2021.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.